Skip to main content
Log in

Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Czaja AJ. Under-evaluated or unassessed pathogenic pathways in autoimmune hepatitis and implications for future management. Dig Dis Sci. 2018;63:1706–1725. https://doi.org/10.1007/s10620-018-5072-x.

    Article  PubMed  Google Scholar 

  2. Matsumoto K, Kikuchi K, Kajiyama Y, et al. Development of autoimmune hepatitis during direct-acting antiviral therapy for chronic hepatitis C virus infection: a case report. Intern Med. 2018;57:2669–2673.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Stewart RA, MacDonald BR, Chu TC, et al. Ledipasvir/sofosbuvir effectively treats hepatitis C virus infections in an underserved population. Dig Dis Sci. 2018. https://doi.org/10.1007/s10620-018-5205-2.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Sugiura A, Wada S, Mori H, et al. Successful treatment for chronic hepatitis C-autoimmune hepatitis overlap syndrome due to daclatasvir and asunaprevir. Case Rep Gastroenterol. 2017;11:305–311.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Giannini EG, Basso M, Savarino V, et al. Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther. 2010;31:502–508.

    Article  CAS  PubMed  Google Scholar 

  6. Dever JB, Ducom JH, Ma A, et al. Engagement in care of high-risk hepatitis C patients with interferon-free direct-acting antiviral therapies. Dig Dis Sci. 2017;62:1472–1479. https://doi.org/10.1007/s10620-017-4548-4

    Article  PubMed  Google Scholar 

  7. Bouma G, van Nieuwkerk CM. Treatment withdrawal in autoimmune hepatitis. Dig Dis. 2015;33:88–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edoardo G. Giannini.

Ethics declarations

Conflict of interest

No financial support was received for this study. The author has no personal interests to declare.

Informed consent

Informed consent was obtained from the patient. No IRB approval is required at our institution for case reports.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Maria, C., Ghidotti, I., Grillo, F. et al. Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis. Dig Dis Sci 64, 591–593 (2019). https://doi.org/10.1007/s10620-018-5356-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5356-1

Keywords

Navigation